Intel (NASDAQ: INTC) stock had a banner year in 2023, but it wasn't because of the company's performance. Investors ignored both a dividend cut and its weak results during a cyclical slowdown in PC sales, and instead bet that the legacy chip stock would be among the winners in th
Tech giants on Tuesday talked up how customers are lapping up their generative AI-powered products, but mounting costs of developing the cutting-edge features irked investors hoping for a big boost to sales from the new technology.
(RTTNews) - While reporting financial results for the fourth quarter on Wednesday, Roper Technologies, Inc. (ROP) initiated its earnings and adjusted earnings from continuing operations as well as revenue growth guidance for the full-year 2024. The company also provided outlook f
(RTTNews) - RADCOM Ltd. (RDCM) reported fourth quarter GAAP net income of $2.6 million, or $0.17 per share, compared to a GAAP net loss of $0.03 million, or breakeven per share, for the fourth quarter of 2022. Non-GAAP net income was $3.8 million, or $0.25 per share, compared to
In recent trading, shares of Verra Mobility Corp (Symbol: VRRM) have crossed above the average analyst 12-month target price of $23.80, changing hands for $23.83/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on
In recent trading, shares of McGrath RentCorp (Symbol: MGRC) have crossed above the average analyst 12-month target price of $125.33, changing hands for $126.43/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v
In recent trading, shares of Vistra Corp (Symbol: VST) have crossed above the average analyst 12-month target price of $41.00, changing hands for $41.23/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation
In recent trading, shares of O'Reilly Automotive, Inc. (Symbol: ORLY) have crossed above the average analyst 12-month target price of $1037.44, changing hands for $1041.12/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: dow
In recent trading, shares of Sanmina Corp (Symbol: SANM) have crossed above the average analyst 12-month target price of $61.75, changing hands for $64.91/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati
In recent trading, shares of Procore Technologies Inc (Symbol: PCOR) have crossed above the average analyst 12-month target price of $72.86, changing hands for $73.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrad
March Nasdaq 100 E-Mini futures (NQH24) are trending down -1.20% this morning as quarterly results from U.S. tech giants failed to meet Wall Street’s high expectations while investors braced for the Federal Reserve’s first interest rate decision of the year.
Boeing Co has "much to prove" to regain the confidence of regulators and customers after a mid-air cabin-panel blowout of a 737 MAX aircraft, CEO Dave Calhoun said on Wednesday, adding that the planemaker will "go slow" as it faces a "serious challenge."
There's a place for stocks trading at low valuations (generally referred to as value stocks) in a well-rounded investment strategy. History shows that the relative performance between value and growth stocks can sometimes move back and forth like a game of tug of war.
Intel Corporation (NASDAQ: INTC) stock lost 12% following the release of its fourth-quarter and full-year 2023 earnings report. Although the 10% revenue growth in Q4 appeared promising, the revenue outlook for Q1 did not meet investor expectations.
With shares already down over 20% year to date, Tesla (NASDAQ: TSLA) has been off to a rocky start in the new year. Its challenges came to a head after the company reported fourth-quarter earnings, and CEO Elon Musk announced vehicle volume growth will be notably lower in 2024 --
(RTTNews) - The year 2024 has begun on a muted note in terms of FDA approvals, with only one novel drug getting endorsed in January. This is in stark contrast to the four drugs that got the regulatory nod during the same month last year.
(RTTNews) - French Media Group Vivendi SA's (VIV.L, VIVEF.PK) Management Board will be exploring the feasibility of a project to split the company into four entities, each of which would be listed on the stock market.
Checked
22 minutes 3 seconds ago
This feed is responsible for generating the rss feed related to the topic META